Cargando…
The TwistDock workflow for evaluation of bivalent Smac mimetics targeting XIAP
Purpose: Mimetics based on Smac, the native inhibitor of XIAP, are promising drug-candidates for the treatment of cancer. Bivalent Smac mimetics inhibit XIAP with even higher potency than monovalent mimetics, but how to optimize the linker that tethers the two monovalent binding motifs remains contr...
Autores principales: | Huang, Qingsheng, Peng, Yin, Peng, Yuefeng, Wei, Dan, Wei, Yanjie, Feng, Shengzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6499140/ https://www.ncbi.nlm.nih.gov/pubmed/31118573 http://dx.doi.org/10.2147/DDDT.S194276 |
Ejemplares similares
-
Targeting XIAP for Promoting Cancer Cell Death—The Story of ARTS and SMAC
por: Abbas, Ruqaia, et al.
Publicado: (2020) -
XIAP impairs Smac release from the mitochondria during apoptosis
por: Flanagan, L, et al.
Publicado: (2010) -
Future Therapeutic Directions for Smac-Mimetics
por: Morrish, Emma, et al.
Publicado: (2020) -
Cannabidiol promotes apoptosis via regulation of XIAP/Smac in gastric cancer
por: Jeong, Soyeon, et al.
Publicado: (2019) -
New light on Smac mimetics and breast cancer
por: Cornmark, L, et al.
Publicado: (2016)